Judge Blocks Kennedy Jr.’s Vaccine Policy Changes, Citing Legal Violations

A federal judge in Boston has temporarily stalled key elements of Health and Human Services Secretary Robert F. Kennedy Jr.’s efforts to reshape U.S. Vaccine policy, citing likely violations of federal law. The ruling, issued Monday, concerns the restructuring of a critical vaccine advisory panel and recent changes to the childhood vaccine schedule implemented in January.

Judge Brian E. Murphy of the U.S. District Court for the District of Massachusetts found that the alterations likely violated the Administrative Procedures Act (APA), which dictates how federal agencies should develop and implement policy changes. The APA requires transparency and reasoned decision-making, including consideration of expert advice and public input. This ruling, while preliminary, represents a significant setback for the Trump administration’s broader overhaul of vaccine policies, even as those reforms continue to unfold.

The Core of the Dispute: Bypassing Established Procedures

At the heart of the legal challenge is the argument that Kennedy Jr.’s administration circumvented the established process for vaccine recommendations. Traditionally, the Advisory Committee on Immunization Practices (ACIP) – a panel of medical and public health experts – plays a central role in advising the Centers for Disease Control and Prevention (CDC) on vaccine schedules. The CDC then issues recommendations based on ACIP’s guidance. The plaintiffs in the case, including the American Academy of Pediatrics, argued that the administration bypassed ACIP when making changes to the childhood immunization schedule, effectively sidelining the expertise of the committee.

Judge Murphy’s 45-page decision echoes this concern, stating that the government “bypassed ACIP to change the immunization schedules, which is both a technical, procedural failure itself and a strong indication of something more fundamentally problematic: an abandonment of the technical knowledge and expertise embodied by that committee.” This isn’t simply a matter of disagreement over vaccine policy; it’s a challenge to the legal framework governing how those policies are made.

Who is Affected by the Ruling?

The immediate impact of the ruling is on the implementation of the revised childhood vaccine schedule. Parents, pediatricians and public health officials are all affected. The changes to the schedule, announced earlier this year, had been intended to align with the administration’s stated goals of providing greater flexibility and parental choice in vaccination decisions. However, the judge’s order effectively puts those changes on hold pending a final resolution of the case.

The American Academy of Pediatrics, a plaintiff in the lawsuit, expressed strong relief at the ruling. Richard Hughes IV, a partner at Epstein Becker & Green representing the AAP, called it a “tremendous victory for science, for public health, and for the rule of law.” The organization has consistently advocated for adherence to evidence-based vaccine recommendations and the established advisory process.

Understanding the Administrative Procedures Act

The Administrative Procedures Act, enacted in 1946, is a cornerstone of U.S. Administrative law. It governs the process by which federal agencies develop and issue regulations. The APA requires agencies to provide notice of proposed rulemakings, solicit public comment, and respond to those comments in a reasoned manner. It similarly requires agencies to base their decisions on substantial evidence and to avoid arbitrary and capricious actions. Cornell Law School provides a detailed overview of the APA.

In this case, the plaintiffs argued that the administration failed to comply with the APA by making significant changes to vaccine policy without following the required procedures. Judge Murphy appeared to agree, finding that the administration’s actions were likely unlawful.

What Does This Mean for Vaccine Policy?

The ruling doesn’t necessarily mean that the administration’s vaccine policies will be permanently blocked. The government could choose to appeal the decision, and the judge’s ruling is currently only a preliminary injunction. However, it does create significant legal hurdles for the administration and raises questions about the legality of its approach to vaccine policy.

The next meeting of the Advisory Committee on Immunization Practices is scheduled for this week. While the specific agenda isn’t yet public, it’s likely that the judge’s ruling will be a topic of discussion. The administration will require to decide how to proceed in light of the court’s decision, and it may need to reconsider its approach to working with ACIP.

The Broader Context: Trump Administration Vaccine Reforms

This legal challenge is part of a larger effort by the Trump administration to reshape U.S. Vaccine policy. Kennedy Jr. Has been a vocal advocate for questioning the safety and efficacy of vaccines, and his appointment as Health and Human Services Secretary signaled a potential shift in the government’s approach to immunization. Reuters reported in February 2026 that Judge Murphy had previously blocked the Trump administration on immigration matters, suggesting a willingness to challenge executive branch actions.

The administration’s reforms have included efforts to increase parental choice in vaccination decisions, to promote vaccine safety research, and to address concerns about vaccine injuries. However, these efforts have also been met with criticism from public health experts who argue that they could undermine vaccination rates and lead to outbreaks of preventable diseases.

Looking Ahead: Procedural Steps and Potential Outcomes

The case will now proceed to further legal proceedings, including discovery and potentially a trial. The government could file a motion for a stay of the preliminary injunction, asking the court to set its order on hold while the case is being litigated. Alternatively, the administration could choose to negotiate a settlement with the plaintiffs or to revise its vaccine policies to comply with the APA. The final outcome of the case will have significant implications for public health in the United States, shaping the future of vaccine policy for years to reach.

The Department of Health and Human Services did not immediately respond to a request for comment on the ruling. What we have is a developing story and will be updated as more information becomes available.